Relationship between B-type natriuretic peptide and adverse outcome in patients with clinical evidence of sepsis presenting to the emergency department

Academic Emergency Medicine

Volumn 18, Issue 2, 2011, Pages 219-222

  Perman, Sarah M ^c   Chang, Anna Marie ^c   Hollander, Judd E ^c   Gaieski, David F ^c   Trzeciak, Stephen ^b   Birkhahn, Robert ^d   Otero, Ronny ^e   Osborn, Tiffany M ^f   Moretti, Eugene ^g   Bryant Nguyen, H ^h   Gunnerson, Kyle J ⁱ   Milzman, David ^j   Goyal, Munish ^a   Cairns, Charles B ^g   Ngo, Long ^a   Rivers, Emanuel P ^a   Shapiro, Nathan I ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b Department of Anesthesiology   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d NEW YORK METHODIST HOSPITAL   (United States)

^e HENRY FORD HEALTH SYSTEM   (United States)

^f UNIVERSITY OF VIRGINIA   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

^h LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

ⁱ VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^j MEDSTAR RESEARCH INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CREATININE; LACTIC ACID;

ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD SAMPLING; BREATHING RATE; CHRONIC KIDNEY FAILURE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC TEST ACCURACY STUDY; DIALYSIS; DISEASE SEVERITY; EMERGENCY WARD; FEMALE; HEART ARREST; HEART RATE; HOSPITAL ADMISSION; HUMAN; INFECTION; LACTATE BLOOD LEVEL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PNEUMONIA; PREDICTIVE VALUE; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RESUSCITATION; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEPSIS; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADULT; AGED; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITAL MORTALITY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; ROC CURVE; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT FAILURE; UNITED STATES;

EID: 79951668615     PISSN: 10696563     EISSN: 15532712     Source Type: Journal    
DOI: 10.1111/j.1553-2712.2010.00968.x     Document Type: Article

References (11)

1. Wang HE, Shapiro NI, Angus DC, Yealy DM,. National estimates of severe sepsis in United States emergency departments. Crit Care Med. 2007; 35: 1928-36. (Pubitemid 47220368)
2. Angus DC, Linde-Zwirble WT, Lidicker J, et al., Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001; 29: 1303-10. (Pubitemid 32641789)
3. Maeder M, Fehr T, Rickli H, Ammann P,. Sepsis induced myocardial dysfunction. Chest. 2006; 129: 1349-66.
4. Rudiger A, Singer M,. Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med. 2007; 35: 1599-608. (Pubitemid 46809326)
5. Brueckmann M, Huhle G, Lang S, et al., Prognostic value of plasma N-terminal pro-brain natriuretic peptide in patients with severe sepsis. Circulation. 2005; 112: 527-34. (Pubitemid 41060793)
6. Lee D, Vasan R,. Novel markers for heart failure diagnosis and prognosis. Curr Opin Cardiol. 2005; 20: 201-10. (Pubitemid 40704877)
7. Shapiro NI, Trzeciak S, Hollander JE, et al., A prospective, multi-center derivation of a biomarker panel to assess risk of organ dysfunction, shock and death in emergency department patients with suspected sepsis. Crit Care Med. 2009; 37: 96-104.
8. American College of Chest Physicians/Society of Critical Care Medicine. Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992; 20: 864-74.
9. Tang WH, Girod JP, Lee MJ, et al., Plasma B-type natriurertic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure. Circulation. 2003; 108: 2964-6. (Pubitemid 37553562)
10. Charpentier J, Luyt CE, Fulla Y, et al., Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med. 2004; 32: 660-5. (Pubitemid 38340060)
11. Rivers EP, McCord J, Otero R, et al., Clinical utility of B-type natriuretic peptide in early severe sepsis and septic shock. Intensive Care Med. 2007; 22: 363-73. (Pubitemid 350132177)